tiprankstipranks
Sino Biopharmaceutical Ltd (DE:SMZ1)
FRANKFURT:SMZ1
Germany Market
SMZ1
Sino Biopharmaceutical
RESEARCH TOOLSreports

Sino Biopharmaceutical (SMZ1) Ratios

0 Followers

Sino Biopharmaceutical Ratios

DE:SMZ1's free cash flow for Q2 2025 was ¥0.82. For the 2025 fiscal year, DE:SMZ1's free cash flow was decreased by ¥ and operating cash flow was ¥0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.36 1.26 1.05 1.29 1.53
Quick Ratio
 1.28 1.14 0.96 1.17 1.41
Cash Ratio
 0.80 0.49 0.42 0.43 0.63
Solvency Ratio
 0.15 0.20 0.13 0.14 0.68
Operating Cash Flow Ratio
 0.13 0.34 0.27 0.31 0.35
Short-Term Operating Cash Flow Coverage
 0.36 0.86 0.54 0.65 0.82
Net Current Asset Value
¥ 4.70B¥ 2.05B¥ -1.63B¥ -185.83M¥ 688.86M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.15 0.20 0.22 0.20
Debt-to-Equity Ratio
 0.36 0.31 0.41 0.47 0.40
Debt-to-Capital Ratio
 0.26 0.23 0.29 0.32 0.29
Long-Term Debt-to-Capital Ratio
 0.08 0.06 0.03 0.12 0.15
Financial Leverage Ratio
 2.24 2.05 2.09 2.15 2.00
Debt Service Coverage Ratio
 0.48 0.70 0.53 0.59 2.62
Interest Coverage Ratio
 0.00 20.79 11.68 13.01 16.46
Debt to Market Cap
 0.12 0.19 0.17 0.18 0.14
Interest Debt Per Share
 0.66 0.58 0.56 0.77 0.66
Net Debt to EBITDA
 -1.57 0.04 0.45 0.80 0.13
Profitability Margins
Gross Profit Margin
82.02%81.51%80.95%82.76%80.15%
EBIT Margin
17.69%17.91%22.54%21.69%70.29%
EBITDA Margin
20.87%21.16%26.64%25.71%73.99%
Operating Profit Margin
20.59%21.26%22.08%21.46%18.91%
Pretax Profit Margin
28.24%18.28%20.65%20.04%69.14%
Net Profit Margin
15.08%12.12%8.90%9.77%54.38%
Continuous Operations Profit Margin
24.42%16.57%17.61%17.36%61.85%
Net Income Per EBT
53.39%66.32%43.10%48.78%78.66%
EBT Per EBIT
137.18%86.01%93.50%93.36%365.71%
Return on Assets (ROA)
4.85%5.35%3.67%3.97%24.13%
Return on Equity (ROE)
11.03%10.95%7.65%8.55%48.23%
Return on Capital Employed (ROCE)
9.90%13.38%14.11%12.72%11.24%
Return on Invested Capital (ROIC)
7.42%10.39%9.45%9.02%8.77%
Return on Tangible Assets
5.06%5.61%3.72%4.09%24.83%
Earnings Yield
3.83%6.71%3.28%3.38%17.50%
Efficiency Ratios
Receivables Turnover
 2.90 5.76 5.70 5.60 6.27
Payables Turnover
 1.53 3.56 3.74 3.08 2.97
Inventory Turnover
 2.06 2.25 2.50 2.49 2.75
Fixed Asset Turnover
 2.39 2.81 2.64 2.81 3.15
Asset Turnover
 0.32 0.44 0.41 0.41 0.44
Working Capital Turnover Ratio
 2.68 9.12 7.50 3.73 2.68
Cash Conversion Cycle
 65.22 123.28 112.22 93.15 68.02
Days of Sales Outstanding
 125.66 63.38 64.03 65.12 58.23
Days of Inventory Outstanding
 177.48 162.32 145.82 146.67 132.64
Days of Payables Outstanding
 237.91 102.43 97.63 118.64 122.85
Operating Cycle
 303.13 225.71 209.85 211.79 190.87
Cash Flow Ratios
Operating Cash Flow Per Share
 0.18 0.38 0.26 0.34 0.29
Free Cash Flow Per Share
 0.16 0.30 0.19 0.24 0.19
CapEx Per Share
 0.02 0.08 0.07 0.09 0.10
Free Cash Flow to Operating Cash Flow
 0.91 0.79 0.72 0.73 0.65
Dividend Paid and CapEx Coverage Ratio
 11.67 2.04 2.60 2.11 1.89
Capital Expenditure Coverage Ratio
 11.67 4.74 3.56 3.67 2.83
Operating Cash Flow Coverage Ratio
 0.26 0.68 0.48 0.45 0.44
Operating Cash Flow to Sales Ratio
 0.13 0.23 0.23 0.24 0.20
Free Cash Flow Yield
3.07%10.01%6.14%6.07%4.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.49 14.90 30.45 29.54 5.71
Price-to-Sales (P/S) Ratio
 4.11 1.81 2.71 2.89 3.11
Price-to-Book (P/B) Ratio
 2.99 1.63 2.33 2.53 2.76
Price-to-Free Cash Flow (P/FCF) Ratio
 34.27 9.99 16.28 16.48 24.04
Price-to-Operating Cash Flow Ratio
 31.58 7.88 11.71 11.99 15.55
Price-to-Earnings Growth (PEG) Ratio
 0.73 0.10 -1.08 -0.34 0.01
Price-to-Fair Value
 2.99 1.63 2.33 2.53 2.76
Enterprise Value Multiple
 18.15 8.57 10.62 12.03 4.33
Enterprise Value
 86.28B 52.37B 74.13B 80.47B 85.98B
EV to EBITDA
 17.18 8.57 10.62 12.03 4.33
EV to Sales
 3.58 1.81 2.83 3.09 3.20
EV to Free Cash Flow
 29.86 10.03 17.00 17.65 24.76
EV to Operating Cash Flow
 27.30 7.92 12.22 12.84 16.02
Tangible Book Value Per Share
 2.37 2.30 1.59 1.93 1.92
Shareholders’ Equity Per Share
 1.85 1.85 1.30 1.60 1.61
Tax and Other Ratios
Effective Tax Rate
 0.12 0.09 0.15 0.13 0.11
Revenue Per Share
 1.34 1.67 1.12 1.40 1.43
Net Income Per Share
 0.20 0.20 0.10 0.14 0.78
Tax Burden
 0.53 0.66 0.43 0.49 0.79
Interest Burden
 1.60 1.02 0.92 0.92 0.98
Research & Development to Revenue
 0.18 0.18 0.17 0.17 0.14
SG&A to Revenue
 0.42 0.42 0.07 0.08 0.08
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 0.00
Income Quality
 0.87 0.95 1.02 1.08 0.29
Currency in CNY